Novem Group Merck & Co., Inc. Transaction History
Novem Group
- $686 Billion
- Q4 2024
A detailed history of Novem Group transactions in Merck & Co., Inc. stock. As of the latest transaction made, Novem Group holds 38,337 shares of MRK stock, worth $3.36 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
38,337Holding current value
$3.36 Million% of portfolio
0.56%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,953Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$22 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.6 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.08 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.36 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $222B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...